Managed Care


March 2010

Some question disease management’s cost-effectiveness, but major insurers have seen enough to induce them to expand programs
Frank Diamond
The most attractive element of the congressional reform plan — at least in the eyes of insurers — is drawing fire in at least 30 states
John Carroll
Many states, helped by a few health plans, are striving to develop health information exchanges, encouraged by federal stimulus funds
Martin Sipkoff
They’re endangered by a brutal combination of factors, a report last August declared, but things may not be so bad as they looked then
Timothy Kelley
Findings of this retrospective database study further emphasize the importance of effectively managing the side effects of opioid pain therapy and achieving optimum clinical and economic outcomes, thus improving the quality of care
Shrividya Iyer, PhD ; Keith L. Davis, MA ; Sean Candrilli, PhD

Editor's Memo
John Marcille
Medication Management
Studies suggest that the benefits of the medications for mild-to-moderate patients are minimal or nonexistent
Martin Sipkoff
Tomorrow's Medicine
Will insurers provide coverage for a new device that takes much of the guesswork out of screening for this deadly skin cancer?
Thomas Morrow, MD
Plan Watch
Disease management should be a function of primary care, some industry proponents argue. Did someone say patient-centered medical home?
Frank Diamond